UPDATED Mar 26, 2024
Companies below a US$500M market cap with strong earnings growth forecasted for the next 3 years.
Company | Last Price | 7D Return | 1Y Return | Market Cap | Analysts Target | Valuation | Growth | Div Yield | ||
---|---|---|---|---|---|---|---|---|---|---|
CDX | AU$0.076 | -5.0% | -68.3% | AU$22.4m | n/a | PS1.6x | E114.3% | n/a | ||
OSSD | kr10.15 | 5.9% | 105.7% | kr991.2m | kr14.67 | PS8.8x | E106.4% | n/a | ||
MYO | US$3.33 | -6.7% | 382.6% | US$96.6m | US$6.79 | PS4.9x | E63.9% | n/a | ||
INVO | US$1.01 | -1.0% | -91.7% | US$2.8m | n/a | PS1.3x | E65.8% | n/a | ||
CRAD B | kr42.50 | 0.5% | 30.4% | kr1.4b | kr58.00 | PE31x | E30.0% | n/a | ||
HSCS | US$0.12 | -5.6% | -88.4% | US$7.9m | n/a | PS422.6x | E66.8% | n/a | ||
DCTH | US$4.61 | 8.5% | -16.8% | US$101.6m | US$19.25 | PS49.2x | E60.3% | n/a | ||
ENL | AU$0.65 | 5.7% | n/a | AU$56.1m | AU$2.33 | PS68.9x | E93.6% | n/a | ||
SYNT | kr27.70 | 0% | -17.6% | kr1.2b | kr30.00 | PE115.2x | E47.4% | 0% | ||
2190 | HK$9.66 | -1.1% | -17.7% | HK$3.2b | HK$15.25 | PS5.5x | E80.9% | n/a | ||
4263 | JP¥558.00 | 7.9% | -53.5% | JP¥9.3b | JP¥700.00 | PE190.5x | E50.7% | n/a | ||
KRSNAA | ₹623.10 | 8.3% | 41.3% | ₹20.1b | ₹951.50 | PE35.3x | E50.1% | 0.4% | ||
IRME | US$1.30 | 8.7% | 232.6% | US$91.2m | US$3.00 | PB75.2x | E84.4% | n/a | ||
ICO | kr8.00 | -1.7% | -79.9% | kr94.0m | kr21.00 | PS3.3x | E59.0% | n/a | ||
HSDT | US$5.58 | -1.6% | -55.4% | US$5.0m | US$17.13 | PS6.2x | E50.6% | n/a | ||
MNTC | kr31.70 | -8.9% | -18.5% | kr810.5m | kr58.33 | PS2.9x | E50.5% | 0% | ||
ORT B | kr10.10 | -1.9% | 24.7% | kr374.5m | kr18.00 | PS6x | E59.0% | n/a | ||
3939 | JP¥499.00 | 1.0% | 2.5% | JP¥23.7b | n/a | PE29.4x | E26.6% | 1.3% | ||
ISPH | ج.م2.77 | 6.1% | 99.4% | ج.م2.9b | ج.م4.08 | PE16.1x | E33.4% | 3.1% | ||
ARTEMISMED | ₹172.75 | 6.0% | 168.7% | ₹23.5b | ₹222.00 | PE51.5x | E43.1% | 0.3% | ||
2279 | HK$1.08 | -20.0% | -86.3% | HK$569.0m | HK$4.10 | PB0.4x | E104.1% | 0% | ||
IBAB | €12.00 | 3.1% | -23.6% | €350.1m | €15.57 | PB4x | E76.9% | 1.8% | ||
INTEG B | kr50.40 | 0.8% | 85.3% | kr929.1m | kr67.00 | PS9.3x | E164.8% | n/a | ||
EQL | kr41.00 | 7.9% | 8.2% | kr1.2b | n/a | PE53.8x | E81.2% | n/a |